IGM Biosciences's total assets for Q2 2025 were $106.99M, a decrease of -48.29% from the previous quarter. IGMS total liabilities were $6.06M for the fiscal quarter, a -97.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.